Trileptal and Dermatitis atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis atopic is found among people who take Trileptal, especially for people who are male, 10-19 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Trileptal and have Dermatitis atopic. It is created by eHealthMe based on reports of 20,849 people who have side effects when taking Trileptal from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

20,849 people reported to have side effects when taking Trileptal.
Among them, 18 people (0.09%) have Dermatitis atopic.


What is Trileptal?

Trileptal has active ingredients of oxcarbazepine. It is often used in bipolar disorder. eHealthMe is studying from 22,317 Trileptal users for its effectiveness, alternative drugs and more.

What is Dermatitis atopic?

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,182 drugs and 427 conditions by eHealthMe.

Number of Trileptal and Dermatitis atopic reports submitted per year:

Could Trileptal cause Dermatitis atopic?

Time on Trileptal when people have Dermatitis atopic *:

  • < 1 month: 50 %
  • 1 - 6 months: 40 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 10 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Dermatitis atopic when taking Trileptal *:

  • female: 50 %
  • male: 50 %

Age of people who have Dermatitis atopic when taking Trileptal *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 55.56 %
  • 20-29: 5.56 %
  • 30-39: 16.67 %
  • 40-49: 16.67 %
  • 50-59: 5.56 %
  • 60+: 0.0 %

Common drugs people take besides Trileptal *:

  1. Zyprexa: 4 people, 22.22%
  2. Depakote: 4 people, 22.22%
  3. Tegretol: 4 people, 22.22%
  4. Oretic: 3 people, 16.67%
  5. Concerta: 3 people, 16.67%
  6. Coumadin: 3 people, 16.67%
  7. Dilantin: 3 people, 16.67%
  8. Norvasc: 3 people, 16.67%
  9. Atarax: 2 people, 11.11%
  10. Clonidine: 2 people, 11.11%

Common side effects people have besides Dermatitis atopic *:

  1. Itching: 7 people, 38.89%
  2. Fever: 5 people, 27.78%
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 22.22%
  4. Skin Fissures (a crack in the skin): 4 people, 22.22%
  5. Nausea (feeling of having an urge to vomit): 4 people, 22.22%
  6. Erythema Multiforme (a type of hypersensitivity reaction): 3 people, 16.67%
  7. Abdominal Pain: 3 people, 16.67%
  8. Blood Alkaline Phosphatase Increased: 2 people, 11.11%
  9. Fall: 2 people, 11.11%
  10. Alanine Aminotransferase Increased: 2 people, 11.11%

Common conditions people have *:

  1. Cerebral Disorder (brain disease): 2 people, 11.11%
  2. Simple Partial Seizures (seizures which affect only a small region of the brain): 1 person, 5.56%
  3. Psychotic Disorder: 1 person, 5.56%
  4. Petit Mal Epilepsy (absence seizure): 1 person, 5.56%
  5. Mood Swings (an extreme or rapid change in mood): 1 person, 5.56%
  6. Constipation: 1 person, 5.56%
  7. Agitation (state of anxiety or nervous excitement): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Trileptal and have Dermatitis atopic?

Check whether Dermatitis atopic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Dermatitis atopic and when was it recovered:

Expand to all the drugs that have ingredients of oxcarbazepine:

Alternative drugs to, pros and cons of Trileptal:

Common Trileptal side effects:

Browse all side effects of Trileptal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Dermatitis atopic treatments and more:

COVID vaccines that are related to Dermatitis atopic:

Common drugs associated with Dermatitis atopic:

All the drugs that are associated with Dermatitis atopic:

Common conditions associated with Dermatitis atopic:

All the conditions that are associated with Dermatitis atopic:

How the study uses the data?

The study uses data from the FDA. It is based on oxcarbazepine (the active ingredients of Trileptal) and Trileptal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: